KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Exact Sciences (EXAS) over the last 12 years, with Q3 2025 value amounting to $7.8 million.

  • Exact Sciences' Non Operating Income rose 29432.91% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year decrease of 8216.53%. This contributed to the annual value of $12.5 million for FY2024, which is 545.76% down from last year.
  • Latest data reveals that Exact Sciences reported Non Operating Income of $7.8 million as of Q3 2025, which was up 29432.91% from $2.1 million recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' Non Operating Income registered a high of $26.6 million during Q1 2021, and its lowest value of -$13.8 million during Q3 2022.
  • Moreover, its 5-year median value for Non Operating Income was -$1.7 million (2024), whereas its average is $253631.6.
  • In the last 5 years, Exact Sciences' Non Operating Income tumbled by 57293.54% in 2022 and then soared by 49839.46% in 2024.
  • Exact Sciences' Non Operating Income (Quarter) stood at -$3.4 million in 2021, then plummeted by 224.47% to -$11.0 million in 2022, then surged by 258.13% to $17.5 million in 2023, then crashed by 97.8% to $385000.0 in 2024, then skyrocketed by 1922.86% to $7.8 million in 2025.
  • Its Non Operating Income stands at $7.8 million for Q3 2025, versus $2.1 million for Q2 2025 and -$5.0 million for Q1 2025.